// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Analysis of the Occupational Health and Wellness of Alberta’s Unionized Insulators: A Cohort Study

S. Kamravaei - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Predictive Identification of Individuals at Risks for Nontuberculous Mycobacterial Lung Disease from a Non-Cystic Fibrosis Bronchiectasis

M. Mirsaeidi - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

N/A

Does Positive Airway Pressure Therapy Reduce the Frequency of Unscheduled Acute Health Care Visits Among Children in Ontario with Obstructive Sleep Disordered Breathing?

D. Radhakrishnan - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Maxillary Expansion Treatment of Obstructive Sleep Apnea in Children - Pilot Study

B. T. Pliska - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Complete Delivery of Medication from a Valved Holding Chamber to a Small Child Is Affected by Chamber Capacity: A Laboratory-Based Investigation

J. Suggett - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Nasal Respiratory Support Does Not Alter Bottle-Feeding in an Ovine Model of Mild to Moderate Respiratory Impairment

N. Samson - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Digibind

Esophageal Pressure: A Reliable Monitoring to Estimate Transpulmonary Pressure in Children?

G. Emeriaud - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Longitudinal Changesin Clinical Characteristics and Outcomes for Children Using Long-TermNon-Invasive Ventilation

M. Castro Codesal - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

The Outpatient Respiratory Care of Children with Sickle Cell Disease: A Quality Improvement Initiative

H. Mohsin - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

N/A

N/A

Translationally Controlled Tumour Protein Inhibits Apoptosis and Promotes Proliferation and Migration of Rat Lung Microvascular Endothelial Cells

M. Ho - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

staurosporine

Splenectomy Deteriorate Chronic Hypoxia-Pulmonary Vascular Remodeling

Y. Zhao - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Splenectomy Blocks the Development of Pulmonary Hypertension in the Monocrotaline Rat Model

Y. Yao - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

Monocrotaline

Prevalence and Impact of Extrapulmonary Deficits on Daily Physical Activity in Fibrotic Interstitial Lung Disease

S. Hur - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Effects of Physical Exercise Training on Nocturnal Symptoms and Sleep Quality in Adults with Asthma: A Systematic Review

C. de Oliveira Francisco - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Body Composition Is Associated with Cumulative Deficits Frailty Index and Metabolic Risk Factors During Lung Transplant Candidacy Evaluation

D. Rozenberg - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Inhibiting HDAC6/RUNX2 Axis as a New Therapeutic Strategy in Idiopathic Pulmonary Fibrosis

G. Vitry - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

The Role of HuR in Myofibroblast Differentiation: Implication for Pulmonary Fibrosis

F. F. AL-Habeeb - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

DE-074

The Genetics of Smoking in Individuals with Chronic Obstructive Pulmonary Disease

M. Obeidat - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Posture-Dependence of the Lung Clearance Index Varies with Disease State in Cystic Fibrosis

J. Rayment - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

N/A

Mapping Lung Microstructural Changes Using Hyperpolarized 129Xe Morphometry in a Rat Model of Bronchopulmonary Dysplasia

A. Lindenmaier - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved